Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
63.65
+1.62 (2.61%)
At close: Jun 26, 2026, 4:00 PM EDT
64.00
+0.35 (0.55%)
After-hours: Jun 26, 2026, 6:10 PM EDT
Nektar Therapeutics Employees
Nektar Therapeutics had 63 employees as of December 31, 2025. The number of employees increased by 2 or 3.28% compared to the previous year.
Employees
63
Change (1Y)
2
Growth (1Y)
3.28%
Revenue / Employee
$883,063
Profits / Employee
-$2,509,492
Market Cap
2.15B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| ADMA Biologics | 647 |
| AbCellera Biologics | 562 |
| Agios Pharmaceuticals | 540 |
| Vericel | 398 |
| Ocular Therapeutix | 325 |
| Nuvation Bio | 307 |
| Kardigan | 241 |
NKTR News
- 1 day ago - Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 23 days ago - Nektar Therapeutics Transcript: AGM 2026 - Transcripts
- 24 days ago - Nektar Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Nektar Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference in New York - PRNewsWire
- 6 weeks ago - Nektar price target lowered to $80 from $95 at Wedbush - TheFly
- 7 weeks ago - Nektar price target raised to $192 from $105 at Piper Sandler - TheFly
- 7 weeks ago - Nektar Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 7 weeks ago - Nektar Therapeutics Earnings release: Q1 2026 - Filings